While the expression and clinical significance of the immune checkpoints PD-L1, B7-H3, and B7-H4 have been reported in common types of cervical cancer [8–11], the immune microenvironment and expression status of immune checkpoints in CCC of the cervix remain unknown. Here, CD276 is linked to cervical carcinoma.